Literature DB >> 16977472

End-stage renal disease as the presenting manifestation of renal systemic lupus erythematosus.

Lavjay Butani1.   

Abstract

About one-half of all children with systemic lupus erythematosus have clinical evidence of renal disease at initial presentation, such as proteinuria and acute renal failure. Herein, we report a case of a teenager who presented with end-stage renal disease (ESRD) of uncertain etiology, and who was subsequently determined to have lupus. The purpose of this report is to make health-care professionals aware of this unusual presentation of renal lupus, which has never been reported before. Children presenting in ESRD should be worked-up for autoimmune diseases since the discovery of such a disease process may impact future decision-making, especially with respect to subsequent renal transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16977472     DOI: 10.1007/s00467-006-0297-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  The long-term prognosis of renal transplantation in patients with lupus nephritis.

Authors:  Gabriella Moroni; Francesca Tantardini; Beniamina Gallelli; Silvana Quaglini; Giovanni Banfi; Francesca Poli; Giuseppe Montagnino; Pierluigi Meroni; Piergiorgio Messa; Claudio Ponticelli
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

2.  Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American pediatric renal transplant cooperative study.

Authors:  S M Bartosh; R N Fine; E K Sullivan
Journal:  Transplantation       Date:  2001-09-15       Impact factor: 4.939

3.  Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.

Authors:  I N Bruce; D C Hallett; D D Gladman; M B Urowitz
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

4.  Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt.

Authors:  Ashraf Bakr
Journal:  Pediatr Nephrol       Date:  2005-06-07       Impact factor: 3.714

5.  Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study.

Authors:  B Bader-Meunier; J B Armengaud; E Haddad; R Salomon; G Deschênes; I Koné-Paut; T Leblanc; C Loirat; P Niaudet; J C Piette; A M Prieur; P Quartier; F Bouissou; M Foulard; G Leverger; I Lemelle; P Pilet; M Rodière; N Sirvent; P Cochat
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

6.  Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare.

Authors:  Simin Goral; Christina Ynares; Scott B Shappell; Shannon Snyder; Irene D Feurer; Rumeyza Kazancioglu; Agnes B Fogo; J Harold Helderman
Journal:  Transplantation       Date:  2003-03-15       Impact factor: 4.939

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis.

Authors:  Young Suck Goo; Hyeong Cheon Park; Hoon Young Choi; Beom Seok Kim; Yong Beom Park; Soo-Kon Lee; Shin Wook Kang; Soon Il Kim; Yu Seun Kim; Ki Il Park; Ho Yung Lee; Dae Suk Han; Kyu Hun Choi
Journal:  Yonsei Med J       Date:  2004-04-30       Impact factor: 2.759

9.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

Review 10.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.